Resources search

Drug resistance as a global health policy priority

NUGENT, Rachel
PICKETT, Jessica
BACK, Emma
January 2008

Expand view

This paper offers an introduction to drug resistance from a global policy perspective. Drug resistance is a growing problem worldwide and is of particular concern in developing country settings. It is a major impediment to the successful treatment of HIV and AIDS, tuberculosis and malaria - the three diseases prioritised for urgent action in developing countries. It also limits treatment options for serious illnesses such as pneumonia and acute diarrhoea, and for other common infections

East African Network for Monitoring Antimalarial Treatment

February 2006

Expand view

The East African Network for Monitoring Antimalarial Treatment (EANMAT) is a local initiative to strengthen the regional information base on parasite chemosensitivity, on which rational treatment policy can be based. The Network was formed in 1997 with three countries: Kenya, Uganda and Tanzania. Rwanda joined in 2000 and Burundi in 2002. The network has high-level commitment and support from the Ministries of Health in the countries involved. EANMAT brings together representatives of the National Malaria Control Programmes (NMCPs) of the member countries, together with other operational and research expertise. This provides a dynamic assessment of current antimalarial treatment, and the data upon which policy change can be based. The website provides a seachable database of malaria treatment efficacy patterns, a map of sentinel sites where this data is gathered, the network's newsletter (including back issues), which comes out three times a year and includes articles about drug efficacy, recent research, and treatment programmes, and a fieldworkers' guide to in vivo anti-malarial drug efficacy testing


Source e-bulletin on Disability and Inclusion

Subscribe to updates